Full-Time

Lead Software Engineer

Quantitative Investment Group

Updated on 9/12/2026

Wellington Management

Wellington Management

1,001-5,000 employees

Global asset management for institutional clients

Compensation Overview

$90k - $180k/yr

+ Discretionary corporate bonus + Incentives

Company Historically Provides H1B Sponsorship

Boston, MA, USA

Hybrid

Four days on-site per week, with flexibility to work remotely one day per week.

Bachelor's

Category
Quantitative Finance (1)
Required Skills
Microsoft Azure
Python
Microsoft SQL Server
Git
Java
C#
AWS
Data Modeling
C/C++
DevOps
Linux/Unix

Get referred to Wellington Management

See people who can refer or advise you

Requirements
  • Experience in object-oriented languages such as C#, C++, or Java.
  • Strong professional experience with Python for data-intensive or analytical applications.
  • Strong software engineering fundamentals, including version control with Git, testing, documentation, logging, and code reviews.
  • Experience designing APIs, services, or shared libraries used by multiple consumers.
  • Experience with AWS, Azure, or other cloud environments.
  • Experience with Microsoft SQL Server.
  • Experience working with large, complex datasets and analytical workflows.
  • Familiarity with time-series data, numerical computation, and data modeling concepts.
  • Interest in or exposure to systematic investment or research-driven environments.
  • Comfort operating in an embedded model with frequent, direct interaction with researchers and Portfolio Managers.
  • Ability to balance rapid iteration with long-term maintainability and platform thinking.
  • Strong communication skills and the ability to translate abstract concepts into robust technology.
  • Five to ten years of professional experience as a software engineer, quantitative developer, or similar role.
  • Bachelor's degree in Computer Science, Engineering, Mathematics, or a related field, or equivalent professional experience.
Responsibilities
  • Partner closely with Portfolio Managers and Quantitative Researchers to understand research workflows and investment objectives.
  • Design and implement software supporting systematic portfolio construction, optimization, rebalancing, and risk analytics across equity and credit strategies.
  • Enable rapid research iteration while maintaining a clear path to production-quality implementations.
  • Ensure consistency and rigor between research prototypes and live portfolio implementation to reduce model and operational risk.
  • Support migration and standardization of systematic models onto next-generation quantitative frameworks.
  • Build and maintain shared time-series and factor data services supporting factor timing, regime analysis, and model execution.
  • Partner with researchers to evolve domain abstractions into durable, well-designed software components.
  • Enable interoperability between legacy research environments and modern Python- and C#-based platforms.
  • Support acquisition, ingestion, and integration of internal and third-party datasets for quantitative research.
  • Design data access patterns supporting time-series correctness, back-testing accuracy, and point-in-time analysis.
  • Collaborate with enterprise data and platform teams to align with firmwide data standards while preserving research velocity.
  • Partner with platform and DevOps teams to create and evolve research and production environments.
  • Contribute to continuous integration and continuous delivery, environment standardization, and operational best practices.
  • Act as a bridge between the Quantitative Investment Group and broader Technology teams to ensure architectural, security, and strategic alignment.
  • Perform basic Linux and Windows system administration.
  • Participate in design discussions, code reviews, and technical standards-setting.
  • Author technical documentation for researchers and technologists.
Wellington Management

Wellington Management

View

Wellington Management is a global investment management firm that offers equity, fixed income, multi-asset, and alternative investments to both institutional clients (such as pension funds, endowments, foundations, and insurers) and individual investors. It manages assets on behalf of clients, earning fees based on assets under management (AUM) and on investment performance. The firm relies on deep research capabilities and market insights to tailor investment strategies that meet client needs, and it integrates environmental, social, and governance (ESG) factors into its process. What sets Wellington Management apart is its broad suite of investment options combined with a commitment to ESG integration and a client-tailored approach, supported by a culture that emphasizes diversity and inclusion. The company’s goal is to help clients achieve their investment objectives by delivering disciplined, research-driven strategies and sustainable investing over the long term.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

$64.9B

Headquarters

Boston, Massachusetts

Founded

1933

Get referred to Wellington Management

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Clay chose Wellington to lead its August 31, 2026 $7 billion financing.
  • WVB funds launched July 22, 2026 on Bank of America wealth platforms.
  • Wellington launched a market-neutral global equity UCITS fund on April 13, 2026.

What critics are saying

  • Wellington cut 170 jobs, over 5%, after a 2025 strategic review.
  • Hartford Funds integration risks distraction until the expected first-quarter 2027 close.
  • Passive giants and private-market rivals squeeze fees, threatening Wellington's $1.35 trillion franchise.

What makes Wellington Management unique

  • Wellington's $1.35 trillion platform spans public markets, private credit, and wealth distribution.
  • Its alliance with Vanguard and Blackstone gives unique access to retail private-market packaging.
  • Hartford Funds acquisition folds U.S. wealth into Wellington's brand by Q1 2027.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive health coverage

Work-life balance

Financial future

Development

Company News

WION
Sep 1st, 2026
Clay raises funding at $7B valuation, more than doubling in a year

Clay, a New York-based startup selling AI tools for sales and marketing teams, has agreed to a new funding round led by Wellington Management at a $7 billion pre-money valuation, Axios reported on 31 August. The round's exact size has not been disclosed, and it is unclear whether it has fully closed. The valuation marks Clay's third jump in about a year, up from $3.1 billion in August 2025 and $5 billion in a January 2026 employee tender offer led by DST Global. The company was founded in 2017 by Kareem Amin and Nicolae Rusan. Clay markets itself as a go-to-market platform that pulls data from over 150 external sources and uses AI agents to research prospects and personalise outbound sales messages. Its customers reportedly include OpenAI, Anthropic, and Canva.

GlobeNewswire
Aug 20th, 2026
Muon Space Closes $250 Million Series C to Scale Space Infrastructure

Muon Space closed a $250M Series C led by Eclipse Capital and joined by Google & Salesforce Ventures to scale constellation production....

PR Newswire
Aug 10th, 2026
Avere Therapeutics raises $500M to advance once-weekly oral IL-23 therapy AVR-001

Avere Therapeutics announced a $500 million private placement to advance AVR-001, its once-weekly oral IL-23 receptor antagonist for inflammatory diseases. Leading healthcare investors including Venrock Healthcare Capital Partners, General Atlantic, Blackstone Multi-Asset Investing, and Wellington Management participated in the funding round. Combined with a previously announced $320 million concurrent private investment, the proceeds will fully fund Avere's operations through 2029. The financing will close alongside Avere's merger with NextCure, expected in the second half of 2026. Upon completion, the combined company will operate as Avere Therapeutics and trade on Nasdaq under ticker symbol "AVRX." Avere is initially developing AVR-001 for psoriasis, with potential expansion into ulcerative colitis, Crohn's disease, and psoriatic arthritis.

Fortune
Aug 7th, 2026
In AI-obsessed Silicon Valley, live commerce platform Whatnot just notched a new funding round valuing it at $20 billion | Fortune

The $545 million Series G nearly doubles Whatnot's valuation—a rare consumer-marketplace breakout at a moment when nearly every venture dollar is flowing to AI.

Central Charts
Aug 6th, 2026
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing to fund Alkeus acquisition

Tarsus Pharmaceuticals has secured $125 million through an oversubscribed private placement equity financing. The transaction includes participation from investors in Alkeus Pharmaceuticals, which Tarsus announced it would acquire earlier the same day. Notable investors include TCGX, Bain Capital Life Sciences, Wellington Management, ADAR1 Capital Management, Sirenia Capital Management LP, RTW Investments, and Vestal Point Capital. The company is selling 2,098,519 shares of common stock at $56 per share and pre-funded warrants to purchase 133,625 additional shares. The financing is expected to close on 7 August 2026. Tarsus intends to use the proceeds to fund clinical development, commercial activities, and general corporate purposes. Barclays is serving as lead placement agent, with BofA Securities and William Blair as co-placement agents.